Sumitomo Mitsui Trust Group
BEAT

Sumitomo Mitsui Trust Group’s BioTelemetry, Inc. BEAT Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-8,911
Closed -$558K – 1048
2019
Q1 		$558K Sell
8,911
-2,786
-24% -$191K ﹤0.01% 893
2018
Q4 		$672K Buy
+11,697
New +$702K ﹤0.01% 844

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sumitomo Mitsui Trust Group's BEAT Position: Q2 2019 in Review

Sumitomo Mitsui Trust Group sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 8,911 shares — an estimated $558K sold.

Sumitomo Mitsui Trust Group first reported a position in BEAT in Q4 2018 and held it in 2 quarters. The position peaked at $672K in Q4 2018. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

  • Sumitomo Mitsui Trust Group reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 8,911 BioTelemetry, Inc. shares in Q2 2019, an estimated $558K.
  • Sumitomo Mitsui Trust Group first reported a position in BioTelemetry, Inc. in Q4 2018 and held it in 2 quarters.
  • Sumitomo Mitsui Trust Group's BioTelemetry, Inc. position peaked at $672K in Q4 2018.
  • 251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2019, filed 29 Jul 2019.